A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease

Related articles

1. CSF complement proteins are associated with early tau pathology and synaptic damage in an asymptomatic population at risk of Alzheimer’s disease

   This article has 12 authors:

   1. Julia Loncke
   2. Mélissa Savard
   3. Cynthia Picard
   4. Henrik Zetterberg
   5. Daniel Auld
   6. Mohamed Badawy
   7. Simon Ducharme
   8. the Alzheimer’s Disease Neuroimaging Initiative
   9. the PREVENT-AD Research Grou
   10. Sylvia Villeneuve
   11. John C. S. Breitner
   12. Judes Poirier

2. Alzheimer’s disease blood biomarkers reveal proteomic modules of disease progression

   This article has 16 authors:

   1. Robert R. Butler
   2. Michael P. Brown
   3. Audrey Weber
   4. Greg A. Cary
   5. Yann Le Guen
   6. Patricia Moran Losada
   7. Justin H. Mendiola
   8. Victor W. Henderson
   9. Sharon J. Sha
   10. Kathleen L. Poston
   11. Katrin I. Andreasson
   12. Anthony D. Wagner
   13. Elizabeth C. Mormino
   14. Tony Wyss-Coray
   15. Frank M. Longo
   16. Edward N. Wilson

3. A leakage-controlled multi-compartment benchmark of fluid biomarkers for predicting mild cognitive impairment to Alzheimer’s disease conversion: plasma, CSF, and high-plex omics in a single cohort

   This article has 1 author:

   1. Ivan Cangas